Leading researchers are a step closer to developing a blood test for Alzheimer’s using a targeted proteomics approach enabled by Myriad RBM’s DiscoveryMAP service.
Leading researchers are a step closer to developing a blood test for Alzheimer’s using a targeted proteomics approach enabled by Myriad RBM’s DiscoveryMAP service.